Previous 10 | Next 10 |
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it will release financial results for the fourth quarter of fiscal year 2023 ended June 30, 2023, before the market open on Tuesday, August 29, 2023. Th...
2023-08-21 16:06:00 ET Summary Equities have pulled back from their late July highs, though the Q2 reporting season has been solid. We spot three firms with unusual corporate event activity. A problem child is back at the top of our volatility watch list, while an airline stoc...
2023-08-15 15:44:44 ET More on Regeneron Pharmaceuticals Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront Regeneron: Eylea Hype Past, But '23 H2 Will Be A Gut Check For fu...
2023-08-03 08:00:28 ET More on Regeneron Regeneron: CRL For High Dose Eylea Gives Vabysmo A Wider Opening Regeneron Pharmaceuticals: Overdependence On Eylea Brought To The Forefront Regeneron: Eylea Hype Past, But '23 H2 Will Be A Gut Check Regeneron cut to N...
2023-08-01 09:44:50 ET Activist hedge fund Third Point is reducing the number of single-name short positions in its portfolio as the short-selling environment is "much more challenging" than it has been historically. "While we have not abandoned short selling, we continue to reduce our ...
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced that Lisa Evoli has been named Senior Vice President & Chief Human Resources Officer, effective immediately. Ms. Evoli joins Catalent from Integra Li...
2023-07-31 08:16:01 ET Summary Today, we take a look at Catalent, a drug manufacturer that has been beset by myriad issues over the past year resulting in a 55% drop in the stock. The company has recently drawn the interest of activist investor Elliott Management, meaning signific...
2023-07-20 13:10:53 ET Catalent Inc ( NYSE: CTLT ) jumped nearly 10% this morning after Elliott Investment Management was reported to have built a sizable stake in the contract drug manufacturer. Elliott is pushing for changes to its board The activist investor has been talk...
2023-07-20 10:44:16 ET Catalent ( NYSE: CTLT ) rose 2.5% amid a report that activist Elliott Investment Management has taken a significant stake in the contract drug maker and plans to push for board changes. Elliott is pushing for changes in the company's board and has be...
2023-07-20 06:36:41 ET Summary Netflix shares fell 7% in premarket trading after Q2 earnings missed revenue expectations but beat profit and subscription forecasts. Tesla shares dropped over 3% premarket after the company failed to boost full-year deliveries guidance and highlight...
News, Short Squeeze, Breakout and More Instantly...
Expansion adds more temperature-controlled storage and dedicated space for FastChain ® demand-led supply service Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced it has completed expansio...
2024-06-30 17:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 07:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for CTLT on June 28, 2024 05:28AM ET. The previous analyst recommendation was Equal-Weight. CTLT was trading at $56.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...